Quick Answer
Pacira BioSciences, Inc. reported Net Income of $7.03 million for fiscal year 2025.
Pacira BioSciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $7.03M | +107.1% |
| 2024 | -$99.56M | -337.3% |
| 2023 | $41.95M | +163.7% |
| 2022 | $15.91M | -62.1% |
| 2021 | $41.98M | -71.2% |
| 2020 | $145.52M | +1421.0% |
| 2019 | -$11.02M | -2238.9% |
| 2018 | -$471.0K | +98.9% |
| 2017 | -$42.61M | -12.3% |
| 2016 | -$37.95M | -2144.7% |
| 2015 | $1.86M | +113.5% |
| 2014 | -$13.72M | +78.5% |
| 2013 | -$63.91M | -22.2% |
| 2012 | -$52.28M | -20.7% |
| 2011 | -$43.33M | -59.6% |
| 2010 | -$27.15M | +14.4% |
| 2009 | -$31.71M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.43M | +103.8% | +212.1% |
| June 30, 2025 | -$4.85M | -125.7% | -200.7% |
| March 31, 2025 | $4.81M | -46.4% | +103.4% |
| September 30, 2024 | -$143.47M | -1421.3% | -859.6% |
| June 30, 2024 | $18.89M | -26.7% | +110.3% |
| March 31, 2024 | $8.98M | +146.0% | -17.3% |
| September 30, 2023 | $10.86M | +1666.8% | -57.9% |
| June 30, 2023 | $25.76M | +29.6% | +231.9% |
- Pacira BioSciences, Inc. showed an increase of +107.1% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, Pacira BioSciences, Inc.’s net income has grown by 122.2% (from -$31.71 million to $7.03 million).
- The most recent figure is from Pacira BioSciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: